These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19943339)

  • 21. Synaptotagmin IV regulates dense core vesicle (DCV) release in LbetaT2 cells.
    Hu ZT; Chen MR; Ping Z; Dong YM; Zhang RY; Xu T; Wu ZX
    Biochem Biophys Res Commun; 2008 Jul; 371(4):781-6. PubMed ID: 18468511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease.
    Hynd MR; Scott HL; Dodd PR
    Neurochem Int; 2004 Oct; 45(5):583-95. PubMed ID: 15234100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMDA receptor-mediated excitotoxicity contributes to the cerebral hypoxic injury of a rat model of posthypoxic myoclonus.
    Tai KK; Truong DD
    Brain Res; 2007 Feb; 1133(1):209-15. PubMed ID: 17196560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential susceptibility to striatal neurodegeneration induced by quinolinic acid and kainate in inbred, outbred and hybrid mouse strains.
    McLin JP; Thompson LM; Steward O
    Eur J Neurosci; 2006 Dec; 24(11):3134-40. PubMed ID: 17156374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurodegeneration and Alzheimer's disease: the lesson from tauopathies.
    Sorrentino G; Bonavita V
    Neurol Sci; 2007 Apr; 28(2):63-71. PubMed ID: 17464468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation.
    Chen JF; Sonsalla PK; Pedata F; Melani A; Domenici MR; Popoli P; Geiger J; Lopes LV; de Mendonça A
    Prog Neurobiol; 2007 Dec; 83(5):310-31. PubMed ID: 18023959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
    Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
    Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration.
    Wyss-Coray T
    J Mol Neurosci; 2004; 24(1):149-53. PubMed ID: 15314264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.
    Tebano MT; Pintor A; Frank C; Domenici MR; Martire A; Pepponi R; Potenza RL; Grieco R; Popoli P
    J Neurosci Res; 2004 Jul; 77(1):100-7. PubMed ID: 15197743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.
    Suzuki T; Araki Y; Yamamoto T; Nakaya T
    J Biochem; 2006 Jun; 139(6):949-55. PubMed ID: 16788045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-beta in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid-beta-induced cell death.
    Leschik J; Welzel A; Weissmann C; Eckert A; Brandt R
    J Neurochem; 2007 Jun; 101(5):1303-15. PubMed ID: 17298384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isoaspartate formation and neurodegeneration in Alzheimer's disease.
    Shimizu T; Watanabe A; Ogawara M; Mori H; Shirasawa T
    Arch Biochem Biophys; 2000 Sep; 381(2):225-34. PubMed ID: 11032409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease.
    Crowther DC; Kinghorn KJ; Miranda E; Page R; Curry JA; Duthie FA; Gubb DC; Lomas DA
    Neuroscience; 2005; 132(1):123-35. PubMed ID: 15780472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-beta 1 is an organizer of responses to neurodegeneration.
    Finch CE; Laping NJ; Morgan TE; Nichols NR; Pasinetti GM
    J Cell Biochem; 1993 Dec; 53(4):314-22. PubMed ID: 8300749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of memantine on soluble Alphabeta(25-35)-induced changes in peptidergic and glial cells in Alzheimer's disease model rat brain regions.
    Arif M; Chikuma T; Ahmed MM; Nakazato M; Smith MA; Kato T
    Neuroscience; 2009 Dec; 164(3):1199-209. PubMed ID: 19733635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-amyloid and glutamate receptors.
    Gasparini L; Dityatev A
    Exp Neurol; 2008 Jul; 212(1):1-4. PubMed ID: 18448101
    [No Abstract]   [Full Text] [Related]  

  • 38. Extended-Synaptotagmins (E-Syts); the extended story.
    Herdman C; Moss T
    Pharmacol Res; 2016 May; 107():48-56. PubMed ID: 26926095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of all 3 Extended Synaptotagmins does not affect normal mouse development, viability or fertility.
    Tremblay MG; Moss T
    Cell Cycle; 2016 Sep; 15(17):2360-6. PubMed ID: 27399837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended synaptotagmins (E-Syts): Architecture and dynamics of membrane contact sites revealed.
    Pérez-Lara Á; Jahn R
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):4837-8. PubMed ID: 25852145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.